6,194 Shares in Ventas, Inc. $VTR Acquired by Vise Technologies Inc.

Vise Technologies Inc. bought a new position in Ventas, Inc. (NYSE:VTR) in the second quarter, according to the company in its most recent disclosure with the SEC. The fund bought 6,194 shares of the real estate investment trust’s stock, valued at approximately $550,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. Dynamic Wealth Strategies LLC purchased a new position in shares of Ventas in the 1st quarter worth $25,000. Wiser Advisor Group LLC purchased a new stake in Ventas during the third quarter valued at $27,000. Meeder Asset Management Inc. bought a new position in Ventas in the second quarter valued at about $30,000. IFC & Insurance Marketing Inc. bought a new position in Ventas in the fourth quarter valued at about $30,000. Finally, Elyxium Wealth LLC purchased a new position in Ventas in the fourth quarter worth about $33,000. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Michael J. Embler acquired 2,500 shares of Ventas stock in a transaction dated Wednesday, June 3rd. The stock was purchased at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.53% of the stock is currently owned by company insiders.

Ventas Stock Performance

Shares of VTR opened at $93.47 on Tuesday. The business has a 50-day simple moving average of $91.56 and a two-hundred day simple moving average of $87.26. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. Ventas, Inc. has a 52 week low of $66.38 and a 52 week high of $101.60. The stock has a market cap of $47.94 billion, a price-to-earnings ratio of 173.09, a PEG ratio of 2.15 and a beta of 0.69.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.96 by $0.01. The firm had revenue of $1.73 billion for the quarter, compared to analysts’ expectations of $1.68 billion. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The business’s quarterly revenue was up 21.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.87 EPS. On average, analysts expect that Ventas, Inc. will post 3.89 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on VTR shares. Citigroup boosted their price target on Ventas from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Tuesday, August 4th. Scotiabank lowered their price objective on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a research note on Thursday, June 18th. KeyCorp boosted their target price on shares of Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Cantor Fitzgerald increased their price target on shares of Ventas from $97.00 to $102.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Finally, Evercore reiterated an “outperform” rating and set a $95.00 price target on shares of Ventas in a research note on Wednesday, April 29th. Fifteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $98.00.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.